Biodesix Inc (BDSX) FY2025Q3 Earning Prediction

11/03 05:00:00

After Hours

Biodesix Inc (BDSX) is set to release its earnings performance on 11/03 05:00:00 in After Hours trading. Consensus forecasts predict a revenue of 20.98M and an earnings per share (EPS) of -1.60 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueBEAT

20.98M

21.77M

+3.76%

EPSBEAT

-1.60

-1.16

+27.50%

AI Summary

Report

Attend Webcast

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

BDSX Transcript

Biodesix, Inc. (BDSX) Q3 2025 Earnings Call Transcript

Positive11-3

The earnings call highlights strong revenue growth, improved gross margins, and a significant reduction in net loss, which are positive indicators. The Q&A section reveals confidence in achieving adjusted EBITDA positivity and a positive outlook on capital needs. However, there are some concerns regarding competition and unclear responses on specific financial metrics. Overall, the positive aspects outweigh the negatives, leading to a positive sentiment rating.

Biodesix, Inc. (BDSX) Q2 2025 Earnings Call Transcript

Positive8-9

The earnings call reflects a positive sentiment with strong revenue growth, a strategic focus on primary care, and digital integration. The Q&A section indicates confidence in revenue-driven EBITDA positivity by Q4, with no major cost-cutting. Although there is an increase in net loss and adjusted EBITDA loss, the overall tone is optimistic, supported by a solid growth strategy and expanding market opportunities. The strategic initiatives and expected revenue acceleration, particularly in Q4, suggest a positive stock price movement in the short term.

Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript

Unknown5-14

The earnings call presents a mixed picture: strong revenue growth and improved margins are positive, but hiring delays and macroeconomic uncertainties pose risks. The Q&A session reveals confidence in the hiring strategy but lacks clarity on revenue impact and efficiency timelines. Despite positive financials, the absence of a share repurchase program and potential hiring delays temper enthusiasm. The company's strategic shift and guidance for profitability in 2025 are encouraging but do not outweigh the uncertainties, resulting in a neutral sentiment for short-term stock price movement.

Biodesix, Inc. (BDSX) Q1 2025 Earnings Call Transcript

Unknown5-13

The earnings call reveals a mixed sentiment. Financial performance shows growth in revenue and improved margins, but there's a net loss and reduced cash reserves. The Q&A section highlights concerns about sales force restructuring and unclear responses from management. Adjusted EBITDA positivity in Q4 2025 and a revised revenue guidance suggest cautious optimism. The lack of clarity and slower hiring may temper market reaction, resulting in a neutral stock price movement prediction.

BDSX Report

Frequently Asked Questions

What is the Biodesix Inc FY2025Q3 Earnings Release Date and Time?

Biodesix Inc (BDSX) is scheduled to release its FY2025Q3 earnings report onNov 3, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Biodesix Inc FY2025Q3 Revenue and EPS?

Analysts' consensus predicts 20.98M in revenue and an EPS of -1.60 for Biodesix Inc's FY2025Q3.

What Does Intellectia's AI Predict for Biodesix Inc FY2025Q3 Earnings?

Intellectia's exclusive AI algorithms forecast a forBiodesix Inc's FY2025Q3 earnings, with a prediction date of Nov 3, 2025. Biodesix Inc

How Can I Use This Earnings Prediction to Trade BDSX Stock?

Leverage Intellectia's AI forecast to position trades ahead of theNov 3, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Biodesix Inc FY2025Q3?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!